Reuters logo
BRIEF-Newron Pharmaceuticals: XADAGO to be introduced in Portugal
April 10, 2017 / 5:39 AM / 7 months ago

BRIEF-Newron Pharmaceuticals: XADAGO to be introduced in Portugal

April 10 (Reuters) - Newron Pharmaceuticals S.p.A.:

* ZAMBON S.p.A., and partner Newron Pharmaceuticals S.p.A., introduce XADAGO (Safinamide) for patients in the middle to late stage of Parkinson’s disease in Portugal

Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below